Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 145.135
1.
Eur. j. psychiatry ; 38(2): [100248], Apr.-Jun. 2024.
Article En | IBECS | ID: ibc-231867

Bacground Pregnancy and postpartum are sensitive periods for mental health problems due to increased stressors and demands, and the prevalence of intentional self-harming behaviors such as suicidal behavior and ideation may increase. Changes in the provision of prenatal care services and utilization of health services and adverse living conditions during the COVID-19 epidemic may also trigger or exacerbate mental illnesses. Aims To investigate the prevalence of suicidal behavior and ideation encountered during pregnancy and postpartum period, its change in the COVID-19 pandemic, and the related factors. Methods A systematic review and meta-analysis of observational studies was conducted. A search was conducted in April 2021 and updated in April 2023 on Web of Science, PubMed, PsycINFO, EBSCO, Turk Medline, Turkish Clinics, and ULAKBIM databases. Two authors independently conducted the search, selection of articles, data extraction, and quality assessment procedures, and an experienced researcher controlled all these steps. Joanna Briggs Institute's Critical Appraisal Checklists were used to assess the quality of the studies. Results The meta-analysis included 38 studies and the total sample size of the studies was 9 044 991. In this meta-analysis, the prevalence of suicidal behavior in women during pregnancy and postpartum periods was 5.1 % (95 % CI, 0.01–1.53), suicidal ideation 7.2 % (95 % CI, 0.03–0.18), suicide attampt 1 % (95 % CI, 0.00–0.07) and suicidal plan 7.8 % (95 % CI, 0.06–0.11). Rate of suicidal behavior, ideation/thought increased and attempts in the pandemic process (2.5% vs 19.7 %; 6.3% vs 11.3 %; 3.6% vs 1.4 %, respectively). Prevalences of suicidal behavior, ideation, attempts, and plan in the postpartum period was higher than during pregnancy (1.1% vs 23.4 %; 6.1% vs 9.2 %; 0.5% vs 0.7 %; 7.5% vs 8.8 %, respectively). ... (AU)


Humans , Female , Pregnancy , Suicidal Ideation , Postpartum Period/psychology , /epidemiology , Pandemics
2.
Washington, D.C.; OPS; 2024-05-06. (OPS/PHE/DRR/COVID-19/23-0019).
Non-conventional Fr | PAHOIRIS | ID: phr-59560

À la mi-janvier 2020, l’Organisation panaméricaine de la Santé (OPS) a mis en place une riposte à la COVID‑19 à l’échelle de l’Organisation, en soutien à ses États Membres et conformément au Plan stratégique de préparation et de riposte de l’Organisation mondiale de la Santé (OMS) à la COVID‑19. Ce plan s’articulait initialement autour de neuf piliers et a été révisé en 2021 pour inclure le pilier 10 (vaccination). En 2022, le plan de riposte actualisé a défini les actions nécessaires pour mettre fin à la pandémie dans la Région. L’OPS a collaboré avec des partenaires dans la Région et dans le monde entier pour fournir une coopération technique, des orientations fondées sur des données probantes et des recommandations pour défendre les intérêts de la Région des Amériques sur la scène internationale. Dès le début de la pandémie, l’Organisation a continué à répondre aux besoins émergents dans sa quête pour détecter, suivre, traiter et ralentir la propagation de la COVID‑19 dans la Région. Les responsables de toutes les entités de l’OPS ont désigné des points focaux pour participer à la mise en œuvre du plan. PHE et PBE ont affecté du personnel dédié pour soutenir le groupe de travail sur l’IREP-C19. Les points focaux ont examiné les recommandations et créé des sous-groupes chargés d’élaborer un plan d’action pour la mise en œuvre. Le plan d’action IREP-C19 résulte de la coordination des chefs de file et co-chefs de file des sous-groupes, et s’appuie sur la participation et la contribution actives des points focaux dans l’ensemble de l’Organisation. compréhension. Les sous-groupes de l’IREP-C19 ont évalué la faisabilité, l’impact potentiel et l’alignement stratégique des axes d’intervention recommandés avec les priorités générales de l’OPS afin de déterminer s’ils devaient être acceptés ou non, ou bien partiellement acceptés ou adaptés. Le groupe de travail sur l’IREP-C19 a élaboré une carte de recommandations pour la mise en œuvre.


COVID-19 , Pandemics , Emergencies , Public Health
3.
Front Public Health ; 12: 1393677, 2024.
Article En | MEDLINE | ID: mdl-38699417

Background: The use of Non-Pharmaceutical Interventions (NPIs), such as lockdowns, social distancing and school closures, against the COVID-19 epidemic is debated, particularly for the possible negative effects on vulnerable populations, including children and adolescents. This study therefore aimed to quantify the impact of NPIs on the trend of pediatric hospitalizations during 2 years of pandemic compared to the previous 3 years, also considering two pandemic phases according to the type of adopted NPIs. Methods: This is a multicenter, quasi-experimental before-after study conducted in 12 hospitals of the Emilia-Romagna Region, Northern Italy, with NPI implementation as the intervention event. The 3 years preceding the beginning of NPI implementation (in March 2020) constituted the pre-pandemic phase. The subsequent 2 years were further subdivided into a school closure phase (up to September 2020) and a subsequent mitigation measures phase with less stringent restrictions. School closure was chosen as delimitation as it particularly concerns young people. Interrupted Time Series (ITS) regression analysis was applied to calculate Hospitalization Rate Ratios (HRR) on the diagnostic categories exhibiting the greatest variation. ITS allows the estimation of changes attributable to an intervention, both in terms of immediate (level change) and sustained (slope change) effects, while accounting for pre-intervention secular trends. Results: Overall, in the 60 months of the study there were 84,368 cases. Compared to the pre-pandemic years, statistically significant 35 and 19% decreases in hospitalizations were observed during school closure and in the following mitigation measures phase, respectively. The greatest reduction was recorded for "Respiratory Diseases," whereas the "Mental Disorders" category exhibited a significant increase during mitigation measures. ITS analysis confirms a high reduction of level change during school closure for Respiratory Diseases (HRR 0.19, 95%CI 0.08-0.47) and a similar but smaller significant reduction when mitigation measures were enacted. Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30-0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98-1.69). Conclusion: Our findings provide information on the impact of COVID-19 NPIs which may inform public health policies in future health crises, plan effective control and preventative interventions and target resources where needed.


COVID-19 , Hospitalization , Interrupted Time Series Analysis , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Italy/epidemiology , Child , Adolescent , Hospitalization/statistics & numerical data , Child, Preschool , Female , Male , Physical Distancing , Hospitals, Pediatric/statistics & numerical data , SARS-CoV-2 , Communicable Disease Control , Infant , Quarantine/statistics & numerical data , Schools , Controlled Before-After Studies , Pandemics
4.
PLoS One ; 19(5): e0280710, 2024.
Article En | MEDLINE | ID: mdl-38701074

PURPOSE: Sexual and gender minority and racialized populations experienced heightened vulnerability during the Covid-19 pandemic. Marginalization due to structural homophobia, transphobia and racism, and resulting adverse social determinants of health that contribute to health disparities among these populations, were exacerbated by the Covid-19 pandemic and public health measures to control it. We developed and tested a tailored online intervention (#SafeHandsSafeHearts) to support racialized lesbian, gay, bisexual, transgender, queer, and other persons outside of heteronormative and cisgender identities (LGBTQ+) in Toronto, Canada during the pandemic. METHODS: We used a quasi-experimental pre-test post-test design to evaluate the effectiveness of a 3-session, peer-delivered eHealth intervention in reducing psychological distress and increasing Covid-19 knowledge and protective behaviors. Individuals ≥18-years-old, resident in Toronto, and self-identified as sexual or gender minority were recruited online. Depressive and anxiety symptoms, and Covid-19 knowledge and protective behaviors were assessed at baseline, 2-weeks postintervention, and 2-months follow-up. We used generalized estimating equations and zero-truncated Poisson models to evaluate the effectiveness of the intervention on the four primary outcomes. RESULTS: From March to November 2021, 202 participants (median age, 27 years [Interquartile range: 23-32]) were enrolled in #SafeHandsSafeHearts. Over half (54.5%, n = 110) identified as cisgender lesbian or bisexual women or women who have sex with women, 26.2% (n = 53) cisgender gay or bisexual men or men who have sex with men, and 19.3% (n = 39) transgender or nonbinary individuals. The majority (75.7%, n = 143) were Black and other racialized individuals. The intervention led to statistically significant reductions in the prevalence of clinically significant depressive (25.4% reduction, p < .01) and anxiety symptoms (16.6% reduction, p < .05), and increases in Covid-19 protective behaviors (4.9% increase, p < .05), from baseline to postintervention. CONCLUSION: We demonstrated the effectiveness of a brief, peer-delivered eHealth intervention for racialized LGBTQ+ communities in reducing psychological distress and increasing protective behaviors amid the Covid-19 pandemic. Implementation through community-based organizations by trained peer counselors supports feasibility, acceptability, and the importance of engaging racialized LGBTQ+ communities in pandemic response preparedness. This trial is registered with ClinicalTrials.gov, number NCT04870723.


COVID-19 , Psychological Distress , Sexual and Gender Minorities , Telemedicine , Humans , Male , COVID-19/prevention & control , COVID-19/epidemiology , COVID-19/psychology , Female , Sexual and Gender Minorities/psychology , Adult , Telemedicine/methods , Middle Aged , SARS-CoV-2 , Young Adult , Health Knowledge, Attitudes, Practice , Depression/prevention & control , Pandemics/prevention & control , Canada/epidemiology
5.
Soc Sci Med ; 350: 116920, 2024 Jun.
Article En | MEDLINE | ID: mdl-38703468

The SARS-CoV-2 (COVID-19) pandemic has impacted the care of people living with HIV (PLWH). This study aims to characterize the impact of the pandemic on the length of HIV treatment gap lengths and viral loads among people living with HIV (PLWH) in British Columbia (BC), Canada, with a focus on Downtown Eastside (DTES), which is one of the most impoverished neighbourhoods in Canada. We analyzed data from the HIV/AIDS Drug Treatment Program from January 2019 to February 2022. The study had three phases: Pre-COVID, Early-COVID, and Late-COVID. We compared results for individuals residing in DTES, those not residing in DTES, and those with no fixed address. Treatment gap lengths and viral loads were analyzed using a zero-inflated negative binomial model and a two-part model, respectively, adjusting for demographic factors. Among the 8982 individuals, 93% were non-DTES residents, 6% were DTES residents, and 1% had no fixed address during each phase. DTES residents were more likely to be female, with Indigenous Ancestry, and have a history of injection drug use. Initially, the mean number of viral load measurements decreased for all PLWH during the Early-COVID, then remained constant. Treatment gap lengths increased for all three groups during Early-COVID. However, by Late-COVID, those with no fixed address approached pre-COVID levels, while the other two groups did not reach Early-COVID levels. Viral loads improved across each phase from Pre- to Early- to Late-COVID among people residing and not residing in DTES, while those with no fixed address experienced consistently worsening levels. Despite pandemic disruptions, both DTES and non-DTES areas enhanced HIV control, whereas individuals with no fixed address encountered challenges. This study offers insights into healthcare system preparedness for delivering HIV care during future pandemics, emphasizing community-driven interventions with a particular consideration of housing stability.


COVID-19 , HIV Infections , Viral Load , Humans , British Columbia/epidemiology , Female , Male , HIV Infections/drug therapy , HIV Infections/epidemiology , COVID-19/epidemiology , Adult , Middle Aged , Viremia/epidemiology , Viremia/drug therapy , SARS-CoV-2 , Pandemics
6.
J Health Econ ; 95: 102882, 2024 May.
Article En | MEDLINE | ID: mdl-38718541

Seasonal infectious diseases can cause demand and supply pressures that reduce the ability of healthcare systems to provide high-quality care. This may generate negative spillover effects on the health outcomes of patients seeking medical help for unrelated reasons. Separating these indirect burdens from the direct consequences for infected patients is usually impossible due to a lack of suitable data and an absence of population testing. However, this paper finds robust empirical evidence of excess mortality among non-COVID-19 patients in an integrated public healthcare system: the English National Health Service (NHS). Analysing the forecast error in the NHS' model for predicted mortality, we find at least one additional excess death among patients who sought medical help for reasons unrelated to COVID-19 for every 42 COVID-19-related deaths in the population. We identify COVID-19 pressures as a key driver of non-COVID-19 excess mortality in NHS hospitals during the pandemic, and characterize the hospital populations and medical conditions that were disproportionately affected. Our findings have substantive relevance in shaping our understanding of the wider burden of COVID-19, and other seasonal diseases more generally, and can contribute to debates on optimal public health policy.


COVID-19 , Hospital Mortality , State Medicine , Humans , COVID-19/mortality , COVID-19/epidemiology , Male , Female , Pandemics , Middle Aged , SARS-CoV-2 , Aged , Adult , England/epidemiology , United Kingdom/epidemiology
7.
Soc Sci Med ; 350: 116919, 2024 Jun.
Article En | MEDLINE | ID: mdl-38728975

OBJECTIVE: Telework was massively adopted during the COVID-19 crisis. Related changes in working conditions may have affected women's and men's health differently due to the gendered division of work. Our study aimed to assess the gendered association of telework with physical and mental health outcomes one year after the onset of the pandemic and to determine whether the pathways of working conditions underlying these associations are gender-related. METHODS: We compared pre-pandemic and Covid-crisis work contexts using a large representative sample of French employees surveyed in early 2021. We identified potential work-related mediators of the relationship between telework and well-being, i.e., change in autonomy, low support, work overload, digital issues, atypical working time, meaning at work, and work-life balance, and used multiple-matching and adjusting for confounders. RESULTS: All things being equal, the health and well-being of teleworkers were, on average, less favourable than that of on-site workers, with little gender differences. The selected working conditions mediated a substantial part of the relationship, indicating that important pathways were captured, such as meaning at work. These pathways partly differed between women and men. In particular, in new teleworkers, the largest contributions came from digital issues for women, and from low support at work and work overload for men. CONCLUSION: People who teleworked during the pandemic were at higher odds of deterioration of health and well-being than onsite workers. Health patterns were similar among male and female teleworkers; however, the pathways differed. These negative effects may yet have been absorbed once the government pandemic response became less stringent.


COVID-19 , Teleworking , Humans , COVID-19/epidemiology , COVID-19/psychology , Female , Male , Adult , France/epidemiology , Middle Aged , Sex Factors , Mental Health , Workplace/psychology , Work-Life Balance , Health Status , SARS-CoV-2 , Pandemics , Surveys and Questionnaires , Workload/psychology , Working Conditions
9.
PLoS One ; 19(5): e0301617, 2024.
Article En | MEDLINE | ID: mdl-38758776

BACKGROUND: In order to gain a deeper understanding of the relationship between physical activity and adolescent mental health in the post COVID-19 pandemic era, self-esteem and social anxiety were used as mediating variables to explore the potential mechanisms by which physical activity affects adolescent mental health. METHODS: The study used the HELP-II Health Promoting Lifestyle Scale, the SPIN Social Phobia Scale, the Self-Esteem Scale, and the 10-item Kessler Psychological Distress Scale to administer questionnaires to 400 Chinese secondary school students, and SPSS 26.0 and PROCESS 3.3 were used to process the data. RESULTS: The findings showed that (1) physical activity was significantly and positively associated with mental health; (2) self-esteem and social anxiety played a fully mediating role between physical activity and adolescent mental health respectively; (3) self-esteem and social anxiety played a chain mediating role between physical activity and adolescent mental health. CONCLUSION: This study reveals the relationship and influencing mechanism between physical activity and adolescent mental health in the post COVID-19 pandemic era. Appropriate interventions for physical activity, self-esteem, and social anxiety may be beneficial to adolescent mental health. The protective role of self-esteem in adolescent mental health should be the focus of future studies, and further investigations into the association between the COVID-19 and adolescent mental health are warranted.


Anxiety , COVID-19 , Exercise , Mental Health , Self Concept , Humans , Adolescent , Female , COVID-19/psychology , COVID-19/epidemiology , Male , Exercise/psychology , Anxiety/psychology , Surveys and Questionnaires , SARS-CoV-2 , Students/psychology , China/epidemiology , Phobia, Social/psychology , Pandemics
10.
Sci Total Environ ; 931: 172813, 2024 Jun 25.
Article En | MEDLINE | ID: mdl-38701924

Cultural ecosystem services (CES) contribute to maintaining and improving human well-being. Understanding the network of interactions involved in co-producing CES is essential for maximizing well-being. In this study, we used social media data to estimate a CES network and assess human-nature interactions underpinning CES co-production. We employed a replicable bottom-up approach, using 682,000 Reddit posts to define a comprehensive repertoire of nature features and human activities, and then sampled the co-occurrence of these features and activities reported in 41.7 million tweets from 2018 to 2022. We expected to observe large changes in the CES network topology in relation to mobility restrictions during the COVID-19 pandemic, but instead the CES network was resilient. However, there was an impulse on the link between self care activities and urban greenspace. This demonstrates that urban greenspaces facilitated local CES production and, thus, provided resilience for maintaining well-being during the pandemic. This study emphasizes the importance of promoting access to nature features that provide CES within local communities.


COVID-19 , Ecosystem , Pandemics , COVID-19/epidemiology , Humans , Social Media , SARS-CoV-2
11.
BMC Public Health ; 24(1): 1338, 2024 May 17.
Article En | MEDLINE | ID: mdl-38760799

BACKGROUND: Health-oriented leadership (HoL) has a positive impact on health- and work-related outcomes of employees in face-to-face settings. Increased digitization during the COVID-19 pandemic has led to many changes and increased job demands. According to current state of research, HoL in virtual teamwork is insufficiently researched. The aim of the study is to examine the experiences of virtual leaders during the COVID-19 pandemic and to identify preconditions and preventive measures for promoting HoL. METHOD: Using a qualitative study design, semi-structured, guide-based telephone interviews were conducted with 16 German virtual leaders between May and July 2021. The collected data were inductively analyzed and interpreted using qualitative content analysis according to Mayring. Explorative analyses of differences between leaders with and without pre-pandemic experiences with virtual leadership were made. RESULTS: Results indicated that leaders, regardless of pre-pandemic experiences with virtual leadership, faced diverse challenges in implementing HoL in virtual teamwork during the COVID-19 pandemic. Virtual leaders perceived personal preconditions (e.g., leaders' characteristics or behaviors), organizational preconditions (support by management or open-minded corporate culture), social preconditions (e.g., social support by team) and technical preconditions (e.g., sufficient technical equipment) as conducive to implementation of HoL. Almost all leaders with pre-pandemic experience identified a need for structural preventive measures, whereas almost all leaders without pre-pandemic experience reported a need for behavioral preventive measures in order to promote HoL in virtual teams. CONCLUSIONS: This study suggests that implementing HoL in virtual teamwork is challenging, complex and requires adjustments in leadership behavior. Thereby, the study provides initial empirical findings for a holistic approach to HoL implementation in virtual teams, considering beneficial multilevel preconditions. Due to a limited generalization of present results, longitudinal and interventional studies will be necessary for the analysis of causal relationships in future research. In particular, a holistic research perspective in order to understand the complex, contextual interdependencies of leadership is recommended. In practice, based on a differentiated needs analysis, structural preventive measures for a holistic organizational development as well as behavioral preventive measures for ongoing personnel development are recommended.


COVID-19 , Leadership , Pandemics , Qualitative Research , Humans , COVID-19/prevention & control , COVID-19/epidemiology , Male , Female , Pandemics/prevention & control , Adult , Middle Aged , Germany , SARS-CoV-2 , Interviews as Topic
12.
Trials ; 25(1): 328, 2024 May 18.
Article En | MEDLINE | ID: mdl-38760804

BACKGROUND: The SARS CoV-2 pandemic has resulted in more than 1.1 million deaths in the USA alone. Therapeutic options for critically ill patients with COVID-19 are limited. Prior studies showed that post-infection treatment of influenza A virus-infected mice with the liponucleotide CDP-choline, which is an essential precursor for de novo phosphatidylcholine synthesis, improved gas exchange and reduced pulmonary inflammation without altering viral replication. In unpublished studies, we found that treatment of SARS CoV-2-infected K18-hACE2-transgenic mice with CDP-choline prevented development of hypoxemia. We hypothesize that administration of citicoline (the pharmaceutical form of CDP-choline) will be safe in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure (HARF) and that we will obtain preliminary evidence of clinical benefit to support a larger Phase 3 trial using one or more citicoline doses. METHODS: We will conduct a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 dose-ranging and safety study of Somazina® citicoline solution for injection in consented adults of any sex, gender, age, or ethnicity hospitalized for SARS CoV-2-associated HARF. The trial is named "SCARLET" (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial). We hypothesize that SCARLET will show that i.v. citicoline is safe at one or more of three doses (0.5, 2.5, or 5 mg/kg, every 12 h for 5 days) in hospitalized SARS CoV-2-infected patients with HARF (20 per dose) and provide preliminary evidence that i.v. citicoline improves pulmonary outcomes in this population. The primary efficacy outcome will be the SpO2:FiO2 ratio on study day 3. Exploratory outcomes include Sequential Organ Failure Assessment (SOFA) scores, dead space ventilation index, and lung compliance. Citicoline effects on a panel of COVID-relevant lung and blood biomarkers will also be determined. DISCUSSION: Citicoline has many characteristics that would be advantageous to any candidate COVID-19 therapeutic, including safety, low-cost, favorable chemical characteristics, and potentially pathogen-agnostic efficacy. Successful demonstration that citicoline is beneficial in severely ill patients with SARS CoV-2-induced HARF could transform management of severely ill COVID patients. TRIAL REGISTRATION: The trial was registered at www. CLINICALTRIALS: gov on 5/31/2023 (NCT05881135). TRIAL STATUS: Currently enrolling.


COVID-19 , Cytidine Diphosphate Choline , Randomized Controlled Trials as Topic , SARS-CoV-2 , Humans , Cytidine Diphosphate Choline/therapeutic use , Double-Blind Method , SARS-CoV-2/drug effects , COVID-19/complications , COVID-19 Drug Treatment , Clinical Trials, Phase II as Topic , Pneumonia, Viral/drug therapy , Pneumonia, Viral/virology , Pneumonia, Viral/complications , Treatment Outcome , Hypoxia/drug therapy , Male , Pandemics , Coronavirus Infections/drug therapy , Coronavirus Infections/complications , Hospitalization , Female , Betacoronavirus , Clinical Trials, Phase I as Topic , Respiratory Insufficiency/drug therapy , Respiratory Insufficiency/virology , Administration, Intravenous , Adult
13.
Nat Commun ; 15(1): 4246, 2024 May 18.
Article En | MEDLINE | ID: mdl-38762653

Since its emergence in December 2019, the COVID-19 pandemic has resulted in a significant increase in deaths worldwide. This article presents a detailed analysis of the mortality burden of the COVID-19 pandemic across 569 regions in 25 European countries. We produce age and sex-specific excess mortality and present our results using Age-Standardised Years of Life Lost in 2020 and 2021, as well as the cumulative impact over the two pandemic years. Employing a forecasting approach based on CP-splines that considers regional diversity and provides confidence intervals, we find notable losses in 362 regions in 2020 (440 regions in 2021). Conversely, only seven regions experienced gains in 2020 (four regions in 2021). We also estimate that eight regions suffered losses exceeding 20 years of life per 1000 population in 2020, whereas this number increased to 75 regions in 2021. The contiguity of the regions investigated in our study also reveals the changing geographical patterns of the pandemic. While the highest excess mortality values were concentrated in the early COVID-19 outbreak areas during the initial pandemic year, a clear East-West gradient appeared in 2021, with regions of Slovakia, Hungary, and Latvia experiencing the highest losses. This research underscores the importance of regional analyses for a nuanced comprehension of the pandemic's impact.


COVID-19 , Pandemics , SARS-CoV-2 , Humans , COVID-19/mortality , COVID-19/epidemiology , Europe/epidemiology , Male , Female , Aged , Middle Aged , Adult , Aged, 80 and over , Young Adult , Adolescent , Mortality/trends
14.
BMC Oral Health ; 24(1): 580, 2024 May 18.
Article En | MEDLINE | ID: mdl-38762726

BACKGROUND: The COVID-19 pandemic exacerbated vulnerabilities and inequalities in children's oral health, and treatment activity virtually ceased during periods of lockdown. Primary care dentistry is still in the post-pandemic recovery phase, and it may be some years before normal service is resumed in NHS dentistry. However, opportunities to support the dental workforce through offering some preventative care in outreach settings may exist. This has the additional benefit of potentially reaching children who do not routinely see a dentist. The aim of this research was therefore to explore views around upskilling practitioners working in early years educational and care settings to support families of pre-school aged children to adopt and maintain preventative oral health behaviours. METHODS: Using the Capability, Opportunity and Motivation model of behaviour (COM-B) to structure our data collection and analysis, we conducted semi-structured interviews with 16 practitioners (dental and non-dental) and analysed the data using deductive framework analysis. RESULTS: The data were a good fit with the COM-B model, and further themes were developed within each construct, representing insights from the data. CONCLUSION: Early years practitioners can reach vulnerable children who are not usually brought to see a dentist, and have the capability, opportunity and motivation to support the oral health behaviours of families of children in their care. Further research is needed to identify training needs (oral health and behaviour change knowledge and skills), acceptability to parents, and supporting dental practice teams to work in partnership with early years settings.


COVID-19 , Health Behavior , Motivation , Oral Health , Parents , Qualitative Research , Humans , COVID-19/prevention & control , Parents/psychology , Parents/education , Child, Preschool , Female , Male , Pandemics , Dental Care for Children , SARS-CoV-2 , Adult , Child
15.
Glob Health Action ; 17(1): 2345970, 2024 Dec 31.
Article En | MEDLINE | ID: mdl-38774927

BACKGROUND: The COVID-19 pandemic affected healthcare delivery globally, impacting care access and delivery of essential services. OBJECTIVES: We investigated the pandemic's impact on care for patients with type 2 diabetes and factors associated with care disruption in Kenya and Tanzania. METHODS: A cross-sectional study was conducted among adults diagnosed with diabetes pre-COVID-19. Data were collected in February-April 2022 reflecting experiences at two time-points, three months before and the three months most affected by the COVID-19 pandemic. A questionnaire captured data on blood glucose testing, changes in medication prescription and access, and healthcare provider access. RESULTS: We recruited 1000 participants (500/country). Diabetes care was disrupted in both countries, with 34.8% and 32.8% of the participants reporting change in place and frequency of testing in Kenya, respectively. In Tanzania, 12.4% and 17.8% reported changes in location and frequency of glucose testing, respectively. The number of health facility visits declined, 14.4% (p < 0.001) in Kenya and 5.6% (p = 0.001) in Tanzania. In Kenya, there was a higher likelihood of severe care disruption among insured patients (adjusted odds ratio [aOR] 1.56, 95% confidence interval [CI][1.05-2.34]; p = 0.029) and a lower likelihood among patients residing in rural areas (aOR, 0.35[95%CI, 0.22-0.58]; p < 0.001). Tanzania had a lower likelihood of severe disruption among insured patients (aOR, 0.51[95%CI, 0.33-0.79]; p = 0.003) but higher likelihood among patients with low economic status (aOR, 1.81[95%CI, 1.14-2.88]; p = 0.011). CONCLUSIONS: COVID-19 disrupted diabetes care more in Kenya than Tanzania. Health systems and emergency preparedness should be strengthened to ensure continuity of service provision for patients with diabetes.


Main findings: The COVID-19 pandemic disrupted diabetes care in Kenya and Tanzania resulting in changes in place and frequency of blood glucose testing, medication prescribed (less oral hypoglycaemics and more insulin), fewer health facility visits and more difficulty accessing healthcare providers.Added knowledge: This study quantifies the impact of the COVID-19 pandemic on diabetes care in Kenya and Tanzania, and describes the factors associated with care disruption in both countries.Global health impact for policy and action: Evidence on diabetes care disruption is useful in making plans and policies responsive to the needs of diabetes patients during pandemics or related emergency situations.


COVID-19 , Diabetes Mellitus, Type 2 , Health Services Accessibility , Humans , Kenya/epidemiology , Tanzania/epidemiology , COVID-19/epidemiology , Diabetes Mellitus, Type 2/therapy , Diabetes Mellitus, Type 2/epidemiology , Male , Female , Cross-Sectional Studies , Middle Aged , Adult , Aged , SARS-CoV-2 , Delivery of Health Care/organization & administration , Pandemics
16.
Glob Public Health ; 19(1): 2355318, 2024 Jan.
Article En | MEDLINE | ID: mdl-38775013

Antimicrobial resistance (AMR) is often framed as a 'silent pandemic,' an invisible crisis unfolding beyond the public gaze. This unseen emergency narrative fuels policy responses aimed at re-establishing human control over antimicrobial use and benefits. In this commentary, we critique the reduction of AMR to a homogenising framework - a product of long-standing paradigms for disease control and elimination. We argue that AMR stems not merely from microbial exposure to drugs, but also involves broader anthropocentric practices. We assert that merely extending AMR concerns to encompass environmental factors is insufficient. Instead, we advocate for a paradigm shift towards a holistic understanding that respects the evolutionary adaptability and survival strategies of microbial life itself. Consequently, a fundamental re-evaluation of large-scale antibiotic use and production is necessary. Rather than seeking to control AMR as a pandemic, we propose exploring the inherent complexity and interdependence of AMR issues. Our proposition advocates for alternative futures that foster collaborations between human and non-human actors, ultimately envisioning a shift in human-microbial relationships towards more integrative health strategies.


Pandemics , Humans , Anti-Bacterial Agents , Drug Resistance, Bacterial , Drug Resistance, Microbial
17.
Pediatr Clin North Am ; 71(3): 383-394, 2024 Jun.
Article En | MEDLINE | ID: mdl-38754931

Pediatric clinic preparedness is essential to improve the care and health outcomes for children during a pandemic and to decrease the burden on hospital systems. Clinic preparedness is a process that involves a well thought out plan that includes coordination with staff, open communication between the clinic and patient families, and collaboration with community partners. Planning for disasters can decrease some of the risks for our most vulnerable patients, including children and youth with special health care needs. There are plans, coalitions, and community partners that can help clinics in their preparedness journey.


COVID-19 , Disaster Planning , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Child , Disaster Planning/organization & administration , Pandemics , Ambulatory Care Facilities/organization & administration , SARS-CoV-2 , Pediatrics/organization & administration
18.
Pediatr Clin North Am ; 71(3): 353-370, 2024 Jun.
Article En | MEDLINE | ID: mdl-38754929

Children make up approximately 25% of the population in the United States and are particularly vulnerable to the impact of disasters. The creation of federally-funded programs and advisory committees has had a positive impact on addressing the needs of children and families in disasters by identifying best practices, disseminating information, identifying gaps, and providing information with future investments that will contribute to expanding disaster science for children and their families.


Disasters , Pandemics , Humans , Child , United States , Disaster Planning/organization & administration , Pediatrics , COVID-19/epidemiology
19.
Pediatr Clin North Am ; 71(3): 455-468, 2024 Jun.
Article En | MEDLINE | ID: mdl-38754935

Pediatric health care providers can provide universal support to children and families to mitigate potential risk factors to adjustment while fostering protective factors to promote resiliency in children and families. They can educate caregivers about ways to enhance recovery of their children by modifying expectations and addressing the special emotional and social needs of their children. Most public health emergencies evolve through stages across an extended time period, often taxing the personal resources of health care providers. This underscores the need for pediatric health care providers to integrate self-care strategies in their personal and professional practice routines.


Pandemics , Humans , Child , Emergencies , Mental Health , Public Health , COVID-19/epidemiology , COVID-19/psychology
20.
Pediatr Clin North Am ; 71(3): 481-498, 2024 Jun.
Article En | MEDLINE | ID: mdl-38754937

Children have unique physiologic, developmental, and psychosocial needs and unique vulnerabilities, making them a challenging population for which to develop therapeutics. This is particularly apparent in the urgent and chaotic environment of a pandemic or outbreak. Advances in the development of medical countermeasures (MCMs) for pediatric populations have grown substantially over the last decade, and the coronavirus disease 2019 pandemic forced advancements in how we approach pediatric MCM development. Consequently, a MCMs pipeline targeting the pediatric population is essential. This article addresses the challenges inherent in these differences that must be taken into account.


COVID-19 , Humans , Child , COVID-19/epidemiology , SARS-CoV-2 , COVID-19 Drug Treatment , Pandemics
...